Margenza Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Margenza General Information

Description

A prescription medicine's global rights for the treatment of cancer. The medicine is for use in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Rockville, MD
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • Rockville, MD
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Margenza Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Margenza‘s full profile, request access.

Request a free trial

Margenza Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Margenza‘s full profile, request access.

Request a free trial

Margenza FAQs

  • Where is Margenza headquartered?

    Margenza is headquartered in Rockville, MD.

  • What industry is Margenza in?

    Margenza’s primary industry is Buildings and Property.

  • Is Margenza a private or public company?

    Margenza is a Private company.

  • What is the current valuation of Margenza?

    The current valuation of Margenza is .

  • What is Margenza’s current revenue?

    The current revenue for Margenza is .

  • Who are Margenza’s investors?

    Macrogenics has invested in Margenza.

  • When was Margenza acquired?

    Margenza was acquired on 12-Nov-2024.

  • Who acquired Margenza?

    Margenza was acquired by Tersera Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process